[Efficacy of different regimens and prognostic factors in patients with first relapsed multiple myeloma treated after front-line bortezomib, cyclophosphamide, and dexamethasone].
Zhonghua Nei Ke Za Zhi
; 62(12): 1436-1443, 2023 Dec 01.
Article
in Zh
| MEDLINE
| ID: mdl-38044070
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Multiple Myeloma
Limits:
Adult
/
Aged
/
Aged80
/
Female
/
Humans
/
Male
/
Middle aged
Language:
Zh
Journal:
Zhonghua Nei Ke Za Zhi
Year:
2023
Document type:
Article
Affiliation country:
China
Country of publication:
China